Goal 2: Reduce Human Disease

Sickle Cell anemia and Aplastic anemia survivors: Late effects and quality of life issues in Stem Cell Transplant Survivors

Most of the patients suffering from non-malignant hematologic conditions are cured of the original disease with Hematopoitec Stem Cell Transplant (HSCT) but still their survival is less compared to age matched general population, and additionally they suffer from unique complications of HSCT culminating into a variety of late physical, psychologic, financial, and social complications (“late effects”). Considerable improvements have occurred in conditioning regimens, provision of alternative donors, and supportive care requirements during HSCT leading to better survival, but the field of HSCT survivorship is still in infancy. Can we provide better long term care to these patients so that we can lessen their mortality and morbidity?

Tags (Keywords associated with the idea)


71 net votes
89 up votes
18 down votes
Idea No. 560